Log In
Print this Print this

zafirlukast (INV104)

  Manage Alerts
Collapse Summary General Information
Company Accolade Pharmaceuticals LLC
DescriptionInhaled formulation of zafirlukast
Molecular Target
Mechanism of ActionNSAID; Leukotriene receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
PartnerInvion Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today